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Given the tremendous importance of mitochondria to basic cellular functions as well as the critical role of mitochondrial impairment in a vast
number of disorders, a compelling question is whether 17β-estradiol (E2) modulates mitochondrial function. To answer this question we exposed
isolated liver mitochondria to E2. Three groups of rat females were used: control, ovariectomized and ovariectomized treated with tamoxifen.
Tamoxifen has antiestrogenic effects in the breast tissue and is the standard endocrine treatment for women with breast cancer. However, under
certain circumstances and in certain tissues, tamoxifen can also exert estrogenic agonist properties. We observed that at basal conditions,
ovariectomy and tamoxifen treatment do not induce any statistical alteration in oxidative phosphorylation system and respiratory chain parameters.
Furthermore, tamoxifen treatment increases the capacity of mitochondria to accumulate Ca2+ delaying the opening of the permeability transition
pore. The presence of 25 μM E2 impairs respiration and oxidative phosphorylation system these effects being similar in all groups of animals
studied. Curiously, E2 protects against lipid peroxidation and increases the production of H2O2 in energized mitochondria of control females. Our
results indicate that E2 has in general deleterious effects that lead to mitochondrial impairment. Since mitochondrial dysfunction is a triggering
event of cell degeneration and death, the use of exogenous E2 must be carefully considered.
© 2007 Elsevier Inc. All rights reserved.Keywords: 17β-Estradiol; Mitochondria; Oxidative phosphorylation system; Ovariectomy; Oxidative stress; Respiratory chain; TamoxifenIntroduction
Breast cancer is the most frequently diagnosed and the
second cause of cancer death in women, thus making breast
cancer a most feared disease. Despite the high incidence, breast
cancer mortality is decreasing and one of the main contributory
factors to this marked improvement in survival has been the
more widespread use of systemic therapy in early-stage disease.
For women with hormone-sensitive cancer, this involves⁎ Corresponding author. Department of Zoology, Faculty of Sciences and
Technology, University of Coimbra, 3004-517 Coimbra, Portugal. Fax. +351
239826798.
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doi:10.1016/j.taap.2007.02.006adjuvant endocrine therapy that reduces estrogen synthesis
(i.e. ovarian suppression in premenopausal women or aromatase
inhibitors in postmenopausal women) or estrogen activity (by
using antiestrogenic compounds, irrespective of menopausal
status) (Kwan et al., 2005). However, many women experience
health and quality-of-life problems related to estrogen defi-
ciency as a result. To circumvent this problem, hormone
replacement therapy (HRT), which includes both estrogen and/
or progestin, has been administered to postmenopausal women.
Although the safety of HRT has been questioned in breast
cancer survivors, it has been shown that HRT may be safe in
women with receptor-negative or receptor-positive cancers in
the presence of tamoxifen (TAM) (Kwan et al., 2005). Indeed,
the synthetic nonsteroidal antiestrogen drug TAM is widely
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and has been proposed as a prophylactic agent against this
disease. TAM undergoes extensive hepatic metabolism being
4-hydroxytamoxifen (OHTAM) and endoxifen its major active
metabolites and responsible for its antiestrogenic activity (Lim
et al., 2006). However, it is now known that under certain
circumstances and in certain tissues, in addition to acting as
competitive inhibitors of endogenous estrogen, estrogen
antagonists can also exert estrogenic agonist properties
(Katzenellenbogen et al., 1996; Sato et al., 1996; McDonnell,
2000).
Mitochondria play a central role in both cell life and death
(Duchen, 2004). Mitochondria are essential for the production of
ATP through oxidative phosphorylation, regulate intracellular
Ca2+ homeostasis and are the principal generators of intracel-
lular reactive oxygen species (ROS). Furthermore, mitochondria
also play a key role in controlling pathways that lead to
apoptosis. Defects of mitochondrial function can result in
excessive production of ROS, formation of the permeability
transition pore (PTP) and the release of small proteins that
trigger apoptosis. Therefore, changes in the structural and
functional characteristics of mitochondria provide a number of
primary targets for drugs-induced toxicity and cell death
(Wallace and Starkov, 2000). Indeed, accumulating evidence
indicates that both 17β-estradiol (E2) (Zheng and Ramirez,
1999; Yang et al., 2004) and TAM (Custodio et al., 1998;
Moreira et al., 2004,2005) modulate mitochondrial function.
The aim of this study was the evaluation of the impact of E2
on liver mitochondria isolated from control, ovariectomized
(mimicking a menopausal state/absence of estrogen) and TAM-
treated ovariectomized (mimicking a breast cancer therapy)
female rats. To achieve our goal, we evaluated several
mitochondrial parameters from the respiratory chain (states 3
and 4 of respiration, respiratory control ratio (RCR) and FCCP-
stimulated respiration), oxidative phosphorylation system
(transmembranar, depolarization induced by ADP and lag
phase), lipid peroxidation parameters (TBARS levels and
oxygen consumption), the capacity of mitochondria to produce
hydrogen peroxide (H2O2), and the susceptibility of mitochon-
dria to permeability transition pore (PTP) opening.
Methods
Chemicals. 17β-Estradiol (E2), 4-(2-hydroxymethyl)-1-piperazineethanesul-
fonic acid (Hepes), cyclosporin A (CsA), oligomycin, ethylene glycol-bis
(β-aminoethylether)NNN′N′-tetraacetic acid (EGTA), tetraphenylphosphonium
(TPP+) were obtained from Sigma Chemical Co and TAM pellets (5 mg per
pellet, 21 d release) from Innovative Research of America, Sarasota, FL. All the
other chemicals were of the highest grade of purity commercially available.
Animals, ovariectomy, and tamoxifen treatment. Female rats (12–15 weeks)
from our animal colony (Laboratory Research Center, University Hospital) were
housed five per cage with ad libitum access to food (URF1-Charles River,
France) and water and maintained at a constant temperature and humidity with a
12 h light/dark cycle. To remove the main source of female hormones, the
animals were bilaterally ovariectomized under anesthesia (i.m.) using ketamine
chloride (88.5 mg/kg, Park Davies, USA) and chlorpromazine chloride
(2.65 mg/kg, Lab. Victoria, Portugal). One week after ovariectomy, pellets
containing placebo (OVX females) or TAM (5 mg per pellet, 21 d release) (TAM
females) that steadily release approximately 0.8 mg/kg/day animals, wereimplanted in the neck of the animals. Additionally, one group of animals was
neither ovariectomized nor implanted (control females). Biochemical analyses
of blood samples collected from cardiac puncture were performed with
commercial Kits used in the Clinical Laboratory of our University Hospital.
Mitochondria preparation. 21 days after the implant of pellets, animals were
euthanized by cervical displacement and decapitation, following procedures
approved by the Institutional Animal Care and Use Committee. Mitochondria
were isolated by conventional methods (Gazotti et al., 1979), with slight
modifications. Briefly, liver mitochondria were isolated in a medium containing
250 mM sucrose, 5 mM Hepes, 0.5 mM EGTA and 0.1% defatted bovine serum
albumin (pH 7.2). EGTA and bovine serum albumin were omitted from the final
washing medium. The mitochondrial pellet was washed twice, and suspended in
the washing medium.
Mitochondrial protein was determined by the biuret method calibrated with
bovine serum albumin (Gornall et al., 1949).
We used liver mitochondria as experimental model for three main reasons: 1)
TAM is extensively metabolized in the liver to give the active metabolites
4-OHTAM and 4-hydroxy-N-desmethyltamoxifen (endoxifen), which have a
greater anti-estrogenic activity than TAM (Fromson et al., 1973; Lim et al.,
2006); 2) the metabolism of estrogens mainly occurs in liver (Tsuchiya et al.,
2005) and 3) mitochondria control steroidogenesis (Felty and Roy, 2005).
Mitochondrial respiration. Oxygen consumption of isolated mitochondria
was monitored polarographically with a Clark oxygen electrode (Estabrook,
1967) connected to a suitable recorder in a thermostated water-jacketed closed
chamber with magnetic stirring. The reactions were carried out at 30 °C in 1 ml
of standard respiratory medium (130 mM sucrose, 50 mM KCl, 2.5 mMMgCl2,
2.5 mM KH2PO4, 5 mM Hepes and 0.1 mM EGTA) with 1 mg of protein. E2
was incubated with isolates 1 min before substrate addition. States 4 and 3
respiration were initiated with 5 mM glutamate/2.5 mM malate and ADP
(150 nmol/mg protein), respectively. Respiration rates were calculated assuming
an oxygen concentration of 240 nmol O2/ml in the experimental medium at
30 °C. States 3 and 4 and respiratory control ratio (RCR=state 3/state 4) were
calculated according to Chance and Williams (1956). FCCP-stimulated
respiration was induced with the addition of 1 μM FCCP added 2 min after
mitochondria energization.
Membrane potential (ΔΨm). The mitochondrial transmembrane potential
(ΔΨm) wasmonitored by evaluating transmembrane distribution of the lipophilic
cation TPP+ (tetraphenylphosphonium) with a TPP+-selective electrode prepared
according to Kamo et al. (1979) using a Ag/AgCl2-saturated electrode as
reference (model MI 402; Microelectrodes, Inc., Bedford, NH). TPP+ uptake has
been measured from the decreased TPP+ concentration in the medium sensed by
the electrode. The potential difference between the selective electrode and the
reference electrode was measured with an electrometer and recorded con-
tinuously in a Linear 1200 recorder. The voltage response of the TPP+ electrode
to log [TPP+] was linear with a slope of 59±1, in a good agreement with the
Nernst equation. Reactions were carried out in a chamber with magnetic stirring
in 1 ml of the standard medium (130 mM sucrose, 50 mM KCl, 2.5 mMMgCl2,
2.5 mMKH2PO4, 100 μMEGTA, 5 mMHepes, pH 7.4) containing 3 μMTPP
+.
This TPP+ concentration was chosen in order to achieve high sensitivity in
measurements and to avoid possible toxic effects onmitochondria (Wingrove and
Gunter, 1986). The ΔΨm was estimated by the equation:
DWm ðmVÞ ¼ 59 logðv=V Þ  59 logð10DE=59  1Þ;
as indicated by Kamo et al. (1979) and Muratsugu et al. (1977). v, V, and ΔE
stand for mitochondrial volume, volume of the incubation medium, and
deflection of the electrode potential from the baseline, respectively. This
equation was derived assuming that TPP+ distribution between the mitochondria
and the medium follows the Nernst equation and that the law of mass
conservation is applicable. A matrix volume of 1.1 μl/mg protein was assumed.
No correction was made for the “passive” binding contribution of TPP+ to the
mitochondrial membranes because the purpose of the experiments was to show
relative changes in potentials rather than absolute values. As a consequence, we
can anticipate a slight overestimation on ΔΨm values. However, the
overestimation is only significant at ΔΨm values below 90 mV, therefore, far
from our measurements.
Table 1
Characterization of control, OVX and TAM-treated OVX females
Control OVX TAM
Body weight gain (%) 18.0±1.7 28.2±6.8⁎ 1.5±1.5⁎⁎,###
RBCs count (×1012/l) 7.3±0.4 7±0.1 6.7±0.3
WBCs count (×109/l) 4.1±0.3 5.6±1.1 5.3±0.7
PLT count (×109/l) 601±210 651±163 730±173
AST (IU/l) 109±2.3 106±4.2 138±8.5⁎,#
ALT (IU/l) 43.3±3.2 35.7±2.4 37±1.8
ALP (IU/l) 71.5±7.7 117±7.1 104±7.3⁎
γ-GT (IU/l) 2.8±0.6 2±0.7 2.4±0.5
Total cholesterol (mg/dl) 47.3±7.9 78.0±7.1⁎ 67.2±11.1#
HDL cholesterol (mg/dl) 30.2±5.6 51.5±5.1⁎ 39.1±7.2#
Triglycerides (mg/dl) 135±27.4 104.5±12⁎ 99.8±16.3⁎
The values are expressed as mean±S.E.M of five to six animals. ∗∗p<0.01;
∗p<0.05 when compared with control females. ###p<0.001; #p<0.05 when
compared with OVX females.
RBCs—red blood cells; WBCs—white blood cells; PLT—platelets; AST—
aspartate aminotransferase; ALT—alanine aminotransferase; ALP—alkaline
phosphatase; γ-GT—γ-glutamyl transferase.
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with 3 μM TPP+ were energized by the addition of 5 mM glutamate/2.5 mM
malate. After a steady-state distribution of TPP+ had been reached (ca. 1 min of
recording) ADP was added and ΔΨm fluctuations recorded. E2 was pre-
incubated 1 min prior mitochondria energization.
Measurements of mitochondrial permeability transition pore (PTP). Oxygen
uptake associated to PTP induction was measured as described above, except
that in this case, mitochondria (1 mg/ml) were suspended in a reaction medium
containing 200 mM sucrose, 10 mM Tris–Mops, 1 mMKH2PO4, 10 μMEGTA,
2 μM rotenone and 0.5 μg oligomycin/ml, pH 7.4, at 30 °C and energized with
succinate. Opening of the pore was induced by Ca2+ addition (70 nmol/mg
protein) after mitochondria energization and prevented by preincubation with
CsA (0.85 μM). E2 was incubated with mitochondria 1 min before energization
with succinate.
Mitochondrial Ca2+ fluxes were measured by monitoring the changes in Ca2+
concentration in the reaction medium using the hexapotassium salt of the
fluorescence probe Calcium Green 5-N (Rajdev and Reynolds, 1993).
Mitochondria (0.5 mg) were resuspended in 2 ml of reaction medium
supplemented with 100 nM of Calcium Green 5-N followed by addition of
Ca2+ (70 nmol/mg protein) and energization with succinate (5 mM). Fluores-
cence was recorded continuously in a water-jacketed cuvette holder at 30 °C
using a Perkin-Elmer spectrofluorometer LS-50 B with an excitation wavelength
of 506 nm (slit 4 nm) and an emission wavelength of 532 nm (slit 6 nm).
Evaluation of oxidative stress. The extent of lipid peroxidation was evaluated
by oxygen consumption monitored polarographically at 30 °C using a Clark-
type oxygen electrode (YSI Model 5331, Yellow Springs Inst) placed in a glass
chamber equipped with magnetic stirring (Santos et al., 2001). Reactions were
carried out in 1 ml of reaction medium containing 175 mM HCl, 10 mM Tris–
HCl, pH 7.4 and 1 mg/ml of protein. Reactions were started by the addition of
1 mM ADP/0.1 Fe2+ and the changes in oxygen tension calculated assuming a
concentration of 240 nmol O2/ml. E2 was incubated with mitochondria for 1 min
before the addition of ADP/Fe2+. In parallel, the extent of lipid peroxidation was
also determined by measuring thiobarbituric acid reactive substances (TBARS),
using the thiobarbituric acid assay, according to a modified procedure as
described elsewhere (Santos et al., 2001). The amount of TBARS formed was
calculated using a molar extinction coefficient of 1.56×105 M−1 cm−1 and
expressed as nmol TBARS/mg protein.
The rate of H2O2 production in isolated mitochondria was determined
fluorimetrically using a modification of the method described by Barja (1999).
Briefly, mitochondria were incubated at 30 °C with 5 mM glutamate/2.5 mM
malate in 1.5 ml of phosphate buffer, pH 7.4, containing 0.1 mM EGTA, 5 mM
KH2PO4, 3 mM MgCl2, 145 mM KCl, 30 mM Hepes, 0.1 mM homovanillic
acid and 6 U/ml horseradish peroxidase in the presence or absence of E2 as
described above. The incubation was stopped at 10 min with 0.5 ml of cold 2 M
glycine buffer containing 25 mM EDTA and NaOH, pH 12. The fluorescence of
supernatants was measured at 312 nm as excitation wavelength and 420 nm as
emission wavelength. The rate of peroxide production was calculated using a
standard curve of H2O2.
Statistical analysis. The results are presented as mean±S.E.M. of the
indicated number of experiments. Statistical significance between the different
assays was made using the one-way analysis of variance (ANOVA) followed by
the Tukey post-test, for multiple comparisons. A p-value <0.05 was considered
statistically significant.
Results
Characterization of animals
OVX females presented a significant increase in body weight
when compared with control females (Table 1). However, TAM
treatment avoided body weight gain (Table 1). Furthermore, we
observed that total cholesterol and HDL-cholesterol were
significantly increased in OVX females when compared withcontrol females. Administration of TAM normalized the levels
of both parameters. However, triglycerides were significantly
decreased in OVX and TAM compared with controls females
(Table 1). We observed also that alkaline phosphatase (ALP)
and glutamate oxaloacetate transaminases (AST) were signifi-
cantly higher in TAM females when compared with control
females. However, no statistical differences were found in red
and white blood cells and platelets count, glutamate pyruvate
transaminases (ALT) and γ-glutamiltransferase (γ-GT) in the
three groups of animals (Table 1).
E2 impairs mitochondrial respiration the effect being more
pronounced in TAM females
We observed that at basal conditions no statistical differences
were observed in states 3 and 4, RCR and FCCP-stimulated
respiration in the three groups of animals studied (Fig. 1).
Incubation of mitochondria with 25 μM E2 induced a
significant decrease in state 3 respiration, RCR and FCCP-
stimulated respiration in mitochondria isolated from the three
groups of animals, when compared with controls at basal
conditions (Figs. 1A, C and D). Furthermore, E2 also induced
an increase in state 4 respiration though only statistically
significant in mitochondria of TAM-treated females when
compared with controls at basal conditions (Fig. 1B).
E2 affects the oxidative phosphorylation system
The mitochondrial transmembrane potential (ΔΨm) is
fundamental for the phenomenon of oxidative phosphorylation,
the conversion of ADP to ATP via ATP synthase. Mitochondrial
respiratory chain pumps H+ out of the mitochondrial matrix
across the inner mitochondrial membrane. The H+ gradient
originates an electrochemical potential (Δp) resulting in a pH
(ΔpH) and a voltage gradient (ΔΨm) across the mitochondrial
inner membrane. ΔΨm developed by mitochondria after
energization with glutamate/malate was ≈−220 mV (negative
inside) (Table 2). As Table 2 shows we did not observe any
Fig. 1. Effect of 17β-estradiol (E2) on states 3 (A) and 4 (B) of respiration, RCR (C) and FCCP-stimulated respiration (D) of mitochondria isolated from control,
ovariectomized (OVX) and tamoxifen-treated ovariectomized (TAM) rat females. Freshly isolated liver mitochondria (1 mg) in 1 ml of the standard medium were
energized with 5 mM glutamate/2.5 mM malate. Isolates were incubated with E2 for 1 min, at 30 °C, before mitochondria energization. ∗∗∗p<0.001; ∗∗p<0.01;
∗p<0.05 when compared with the respective basal condition. Data shown represent mean±S.E.M. from six animals for each experimental group studied.
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the three groups of animals at basal conditions as well as when
incubated with E2. Furthermore, we observed that at basal
conditions the depolarization induced by ADP and the lag phase
(time necessary for ADP phosphorylation) did not alter
significantly in all groups of animals tested. However, both
parameters were significantly increased when mitochondria
were incubated with E2 (Table 2).
E2 does not interfere with PTP: protective effect of TAM
When PTP is induced, acceleration of mitochondrial
respiration and alteration of Ca2+ fluxes are commonly
observed, and these changes are often used as a simple
means to judge whether or not a PTP is induced. We observed
that after the addition of 70 nmol Ca2+/mg protein, oxygen
consumption is less pronounced in mitochondria isolated from
TAM females (OVX+TAM) when compared with control and
OVX females (Fig. 2). However, the lower consumption of
oxygen occurred when mitochondria were incubated with CsA,Table 2
Effect of E2 on oxidative phosphorylation parameters of mitochondria isolated from
Control Control+E2
ΔΨm (−mV) 219.1±1.75 219.6±1.26
Depolarization induced by ADP (−mV) 31.2±1.63 34.8±2.28∗
Lag phase (min) 1.17±0.07 2.67±0.18∗
The values are expressed as mean±S.E.M of five to six animals. ∗∗p<0.01; ∗p<0.the specific inhibitor of PTP (Fig. 2). Again, the presence of E2
did not affect significantly oxygen consumption (Fig. 2). When
we measured Ca2+ fluxes, the protective effect of TAM was
pronounced (Fig. 3). Indeed, we observed that isolated mito-
chondria from TAM females incubated with 70 nmol Ca2+/mg
protein rapidly accumulate and retained the Ca2+ from the
medium this effect being similar to that exerted by CsA (Fig.
3). In contrast, mitochondria from OVX and control females
accumulate Ca2+ from the medium but after some time they
release the accumulated Ca2+ (Fig. 3). The drop of ΔΨm is
also a typical phenomenon that leads to the induction of PTP.
We observed that in energized mitochondria isolated from the
three groups of animals the first and second pulses of 30 nmol
Ca2+/mg protein led to a rapid depolarization followed by an
almost complete reestablishment of ΔΨm (repolarization).
However, a third pulse of 10 nmol Ca2+/mg protein led to an
irreversible loss of ΔΨm this effect being slowed (delayed) in
mitochondria isolated from TAM animals. The presence of E2
did not affect significantly the effect of Ca2+ in all conditions
tested (data not shown).control, OVX and TAM-treated OVX females
OVX OVX+E2 TAM TAM+E2
217.3±2.01 214.8±2.10 220.5±2.74 219.1±2.99
29.2±1.76 34.3±1.27∗ 30.4±1.85 35.8±1.73∗
1.20±0.26 2.01±0.41∗∗ 1.04±0.28 2.19±0.57∗
05 when compared with control females.
Fig. 2. Effect of 17β-estradiol (E2) on Ca2+-induced oxygen consumption of
mitochondria isolated from control, ovariectomized (OVX) and tamoxifen-
treated ovariectomized (OVX+TAM) rat females. Freshly isolated liver
mitochondria (1 mg) in 1 ml of the standard medium were energized with
5 mM succinate (succ). Isolates from TAM females were incubated with E2 for
1 min, at 30 °C, before mitochondria energization. Cyclosporin A (CsA)
(0.85 μM) was added to the reaction medium 2 min prior to Ca2+ (70 nmol/mg
protein) addition. The traces are typical of six experiments.
106 P.I. Moreira et al. / Toxicology and Applied Pharmacology 221 (2007) 102–110E2 protects against lipid peroxidation
Oxygen consumption and TBARS levels were used to
determine the extension of lipid peroxidation (PX) induced by
ADP/Fe2+. We observed that maximal oxygen consumption
occurs first in OVX (Fig. 4B) followed by TAM (Fig. 4C) and,
finally, control (Fig. 4A) females. However, after 10 min there isFig. 3. Effect of tamoxifen (TAM) on Ca2+ fluxes of mitochondria isolated from
control, ovariectomized (OVX) and tamoxifen-treated ovariectomized (OVX+
TAM) rat females. Freshly isolated liver mitochondria were incubated at
0.25 mg/ml under standard conditions as described in the Methods section.
Standard medium was supplemented with 70 nmol Ca2+/mg protein 1 min
before mitochondria energization with 5 mM succinate (succ). Cyclosporin A
(CsA) (0.85 μM) or TAMwere added to the reaction medium 2min prior to Ca2+
addition. The traces are typical of six experiments.
Fig. 4. Effect of 17β-estradiol (E2) on oxygen consumption induced by lipid
peroxidation (Px). Mitochondria isolated from control, ovariectomized (OVX)
and tamoxifen-treated ovariectomized (TAM) rat females were incubated at
1 mg/ml under standard conditions as described in the Methods section. Isolates
were pre-incubated with E2 (PX+E2) for 1 min, at 30 °C, before the addition of
ADP/Fe2+ (PX). Data shown represent mean±S.E.M. from six animals for each
experimental group studied.no statistical difference in the levels of oxygen consumption
when the three groups of females were compared. However, the
presence of E2 decreased significantly the effects of ADP/Fe2+
in the three groups of animals and, in control females these
levels are similar to those at basal conditions (Fig. 4).
Accordingly, after 10 min of PX the levels of TBARS are
similar in the three groups of animals studied (Fig. 5). The
presence of E2 decreased significantly those levels this effect
being more pronounced in control females where the levels of
TBARS induced by ADP/Fe2+ are similar to the levels occurring
at basal conditions (Fig. 5).
Fig. 5. Effect of 17β-estradiol (E2) on TBARS levels. Mitochondria isolated
from control, ovariectomized (OVX) and tamoxifen-treated ovariectomized
(TAM) rat females were incubated at 1 mg/ml under standard conditions as
described in the Methods section. Isolates were pre-incubated with E2 (PX+E2)
for 1 min, at 30 °C, before the addition of ADP/Fe2+ (PX). Data shown represent
mean±S.E.M. from six animals for each experimental group studied.
∗∗∗p<0.001, ∗∗p<0.01 when compared with the respective basal condition.
###p<0.001 when compared with PX condition.
Fig. 6. Effect of 17β-estradiol (E2) on mitochondrial H2O2 production. Freshly
isolated liver mitochondria were incubated at 0.2 mg/ml under standard
conditions as described in the Methods section. Data shown represent mean±
S.E.M. from six animals for each experimental group studied. ∗∗∗p<0.001
when compared with the energized basal condition. ###p<0.001 when
compared with energized control condition in the presence of E2.
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of control females
In the absence of substrate the capacity of mitochondria to
produce H2O2 in the presence/absence of E2 is similar in the
three groups of animals studied (Fig. 6). Although energized
mitochondria, at basal conditions, produce higher levels of
H2O2, that increase was not statistically significant. However,
the presence of E2 induced a significant increase in H2O2
production in energized mitochondria of control females.
Discussion
This study shows that E2, despite its protector effect against
lipid peroxidation, affects profoundly liver mitochondrial
function which is not consistent with the bulk of the literature
focussing the effects of E2 (Lu et al., 2007; Nilsen et al., 2006).
Furthermore, we observed that TAM-treatment per se delay PTP
opening supporting previous data from the literature (Custodio
et al., 1998; Moreira et al., 2005). Furthermore, our study also
shows that TAM treatment and ovariectomy induce alterations
in biochemical parameters as well as in body weight.
We observed that ovariectomy induces a body weight gain
while TAM treatment avoids body weight gain (Table 1). It has
been shown that menopause is associated with a decrease in the
resting metabolic rate that reduces the utilization of calories and
hence increases body weight (van Seumeren, 2000). Further-
more, previous studies also reported that treatment of
ovariectomized rats with TAM mimics the effects of E2 and
causes significant decreases in food intake and body weight
(Wade and Heller, 1993). The decreases in body weight are
reflected mainly in a decreased body fat content and, similar to
the effects of E2, TAM decreases parametrial white adipose
tissue wet weight and lipoprotein lipase activity (Wade and
Heller, 1993). Recently, Lopez and collaborators (2006)reported that the anorectic effect of TAM is associated with
the accumulation of malonyl-CoA in the hypothalamus and
inhibition of fatty acid synthase expression specifically in the
ventromedial nucleus of the hypothalamus.
Approximately 40% of total cholesterol removal occurs by
conversion to bile acids, a process that takes place in the liver.
Recently, Czerny et al. (2005) reported that ovariectomy causes
decreased excretion of bile and bile acids. Furthermore, they
reported that TAM and raloxifene administration do not reverse
the changes in bile composition induced by estrogen deficiency.
We also observed that ovariectomy increases total and HDL
cholesterol but, in this study, TAM treatment reversed these
effects (Table 1). Furthermore, the effects of raloxifene on lipids
and lipoproteins in 2659 women with either normal or high
triglyceride levels have been studied (Dayspring et al., 2006). In
both triglyceride subgroups, raloxifene significantly improved
low-density lipoprotein cholesterol, total cholesterol, non-high-
density lipoprotein cholesterol (HDL-C), apolipoprotein B,
apolipoprotein A-I, and fibrinogen compared with placebo
(Dayspring et al., 2006). Recently, Liu et al. (2006) investigated
the changes in serum aspartate aminotransferase and alanine
aminotransferase levels in patients with breast cancer treated
with TAM. They observed that 115 patients had elevations of
aspartate aminotransferase, alanine aminotransferase or both,
although the magnitude of the elevation was clinically
significant only in 32 patients. Furthermore, El-Beshbishy
(2005) showed that TAM induces increases in serum glutamate
pyruvate transaminase and serum glutamate oxaloacetate
transaminase in rat females. Accordingly, we also observed
that TAM treatment alters transaminases (Table 1), which is an
expected result since TAM is extensively metabolized in the
liver (Fromson et al., 1973).
Mitochondria are organelles essential for generating energy
that fuels normal cellular function and, at the same time, are the
major intracellular source of cytotoxic free radicals and the
primary determinants of cell death (Green and Kroemer, 2004).
The unique role of the mitochondria is in supplying high-energy
ATP molecules, while at the same time, monitoring cellular
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cell death. As such, mitochondria sit at a strategic position in the
hierarchy of cellular organelles to continue the healthy life of the
cell or to terminate it.
We observed that at basal conditions neither ovariectomy nor
TAM treatment induce any significant alteration on mitochon-
drial respiratory parameters (Fig. 1). However, we observed that
the respiratory chain is profoundly affected by E2 this effect
being more evident in TAM treated females (Fig. 1). Although
E2 acts as a partial uncoupler (Fig. 1B) it is more an inhibitor of
respiration than an uncoupler because it does not inhibit the
uncoupling effect of FCCP (Fig. 1D). We also observed that E2
impairs the oxidative phosphorylation system (Table 2). These
data are supported by a previous in vitro study from our
laboratory that showed that lower concentrations of TAM that do
not interfere with mitochondrial function, in the presence of E2
significantly affect the function of these organelles. Further-
more, we were able to show that TAM and E2 act directly on the
flavin mononucleotide (FMN) site of complex I leading to
mitochondrial failure (Moreira et al., 2006). Although these
results were obtained with liver mitochondria isolated frommale
rats, preliminary results from our laboratory show the same
effects in mitochondria isolated from female rats though less
pronounced. Differences between genders are supported by
previous studies that showed that mitochondria from females
suffer less oxidative damage in critical biomolecules such as
mitochondrial DNA and glutathione as compared with males
(Borras et al., 2003; Vina et al., 2003). Indeed, the authors
reported that levels of 8-oxodeoxyguanosine, a marker of DNA
oxidative damage, are four times greater in mitochondria from
males than in females while mitochondrial GSH levels are
double in females than in males. In addition, it has been shown
that brain and liver mitochondria isolated from female rats and
mice produce approximately half the amount of H2O2 generated
by mitochondria isolated from males (Borras et al., 2003).
At this point it is important to note that although estrogen
synthesis occurs in the mitochondria, exogenously added
estrogen is also transported to this organelle. For instance, in
vivo exposure of ovariectomized rats to tritiated E2 showed with
increasing time, the translocation of this hormone from the
plasmalemma mainly to the mitochondria (75%) rather than the
nuclei in liver, adrenal gland, and spleen tissues (Moats and
Ramirez, 1998). The lipophilic property of E2 allows this
molecule to easily diffuse into lipid bilayers. Since mitochon-
dria are enriched with lipids, the organelle has the ability to act
as an estrogen-sink within cell.
In this study, we observed that TAM treatment increases
mitochondrial Ca2+ uptake delaying PTP induction (Figs. 3 and
4). The PTP causes a non-selective permeabilization of the inner
mitochondrial membrane typically promoted by the accumula-
tion of excessive quantities of Ca2+ ions and stimulated by a
variety of compounds or conditions (Zoratti and Szabo, 1995).
In this study, the classic inductor Ca2+ was used to induce PTP
opening (Figs. 2 and 3). Accordingly, previous in vitro studies
also indicate that TAM (Custodio et al., 1998; Moreira et al.,
2005) and OHTAM (Cardoso et al., 2002; Moreira et al., 2004)
are potent inhibitors of PTP induction in liver and brain mito-chondria. However, we observed that E2 exposure does not
interfere with Ca2+ influx (Fig. 2). Previously, Petrovic and
collaborators (2005) observed that in vitro E2 exposure does not
interfere on Ca2+ influx through ruthenium red-sensitive
channels in synaptosomal mitochondria of chronically ovar-
iectomized female rats.
In contrast with the other parameters analyzed in this study,
PTP experiments were done with succinate, a substrate of
mitochondrial complex II. From the bioenergetics point of view,
the choice of succinate as substrate tends to provide the most
consistent results because succinate oxidation does not require
matrix pyridine nucleotides, which can be lost via the PTP
during storage or incubation even when swelling is undetectable
(Vinogradov et al., 1972). Furthermore, our previous in vitro
study with liver mitochondria isolated from male rats (Moreira
et al., 2006) as well as our preliminary results obtained from
female rats show that E2 affects mitochondrial complex I. To
avoid interferences in Ca2+ fluxes induced by E2 on
mitochondrial complex I, we used succinate as mitochondrial
substrate.
We observed that lipid peroxidation occurs faster in
mitochondria isolated from OVX females (Fig. 4B) when
compared with TAM (Fig. 4C) and control (Fig. 4A) females.
Besides their chemopreventing function, TAM and OHTAM,
which are extremely lipophilic (Custodio et al., 1991, 1993),
induce multiple cellular effects, including antioxidant actions
since they are strong intramembranous scavengers of peroxyl
radicals (Custodio et al., 1994). The presence of E2 exerted a
significant protection against ADP/Fe2+-induced lipid perox-
idation (Figs. 4A, B, C and 5). Accordingly, recent studies have
shown that although ovariectomy leads to oxidative damage in
liver (Oztekin et al., 2006a) and renal tissue (Oztekin et al.,
2006b), female sex hormones (E2 and progesterone) supple-
mentation protect against lipid peroxidation by activating the
antioxidant system. In the same line, it has been shown that
postmenopausal women tend to have high levels of plasma
malondialdehyde (MDA) that are reversed by estrogen
replacement therapy (Kumru et al., 2005). Similarly, Wang
and collaborators (2006) using human neuroblastoma SK-N-SH
cells as experimental model, reported that E2 effectively reduce
lipid peroxidation induced by 5-min H2O2 exposure. Moreover,
the authors observed that the estrogen receptor antagonist
fulvestrant (ICI 182,780) did not block the effects of E2 (Wang
et al., 2006) supporting previous findings from our laboratory
indicating that the effects of E2 on liver mitochondria are
estrogen-receptor independent (Moreira et al., 2006). Although
we observed that E2 exerts a strong protective effect against
lipid peroxidation (Figs. 4 and 5) it also induces a significant
increase in H2O2 production in energized mitochondria of
control females (Fig. 6). To clarify this apparent paradox, we
measured the basal activities of manganese superoxide
dismutase (MnSOD) and glutathione peroxidase (GPx), two
important enzymes that detoxify ROS. The detoxification of
superoxide (O2
·−) is a two-stage reaction involving, in a first
step, SOD that catalyzes the reduction of O2
·− to H2O2, itself a
very damaging reactive molecule via the Fenton reaction and, in
the second stage involves the reduction of H2O2 to H2O by GPx.
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decrease in the activity of MnSOD while GPx activity is slightly
increased in control rats when compared with ovariectomized
and tamoxifen-treated ovariectomized female rats (data not
shown). In accordance we observed a slightly reduced
production of H2O2 in unenergized (presence/absence of E2)
and energized (absence of E2) mitochondria of control females
when compared with ovariectomized and TAM-treated ovar-
iectomized females (Fig. 6). By contrast, in the presence of E2
the levels of H2O2 produced by energized mitochondria of
control females increases significantly (Fig. 6). However,
previous studies showed that GPx is important not only in the
detoxification of H2O2 but also participates in the detoxification
of lipid hydroperoxides using glutathione in this process
(McCray et al., 1979), which is in accordance with our lipid
peroxidation results (Figs. 4 and 5). Furthermore, it has been
reported that GPx is involved in redox sensing pathways and
redox regulation of metabolic events (Brigelius-Flohe, 2006).
Little is known about the protective signalling cascades that are
activated by oxidative stress under normal metabolic condi-
tions. These signalling pathways are activated by mitochondrial
or cytoplasmic proteins that detect an increase in ROS and lead
to the increased expression of genes encoding proteins
responsible for cellular and mitochondrial detoxification
(Storz, 2006). H2O2 is a small and uncharged molecule that
can freely diffuse through cellular membranes and represents an
unquestionable long-range second messenger signalling (Fin-
kel, 2003). There is evidence that H2O2 can activate many
components of intracellular signalling cascades that are
involved in cell survival, proliferation, differentiation and cell
death (Boyd and Cadenas, 2002). Recently, it has been shown
that rapid E2-induced changes in mitochondrial ROS produc-
tion and mitochondrial Ca2+ are involved in cell cycle
progression presumably through the control of early cell cycle
genes (Parkash et al., 2006).
Overall our results indicate that, in general, exogenous E2
modulates negatively mitochondria suggesting that HRT should
be considered carefully. However, more studies will be useful in
resolving the controversy about the risks versus benefits of E2
supplementation.
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